Summit Securities Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-685
| Closed | -$5.36K | – | 949 |
|
|
2025
Q1 | $5.36K | Buy |
+685
| New | +$5.36K | ﹤0.01% | 470 |
|
|
2024
Q1 | – | Sell |
-2,422
| Closed | -$34K | – | 329 |
|
|
2023
Q4 | $34K | Buy |
+2,422
| New | +$34K | ﹤0.01% | 252 |
|
|
2015
Q3 | – | Sell |
-600
| Closed | -$13K | – | 312 |
|
|
2015
Q2 | $13K | Buy |
+600
| New | +$13K | 0.01% | 353 |
|